Paper4279136
A review of chemotherapy in gastric cancer.
Comis RL and 1 other. Cancer, 1974. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. A review of chemotherapy in gastric cancer. Papers, record 4279136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4279136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Stomach Neoplasms | Major topic |
| Adenocarcinoma | |
| Carmustine | |
| Chlorambucil | |
| Chromomycins | |
| Cyclophosphamide | |
| Cytarabine | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Floxuridine | |
| Fluorouracil | |
| Humans | |
| Mechlorethamine | |
| Methotrexate | |
| Mitomycins | |
| Nitrosourea Compounds | |
| Olivomycins |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01671449 | S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer | Background |
Source ClinicalTrials.gov
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31205469 | LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer. | J Oncol | 2019 | https://conductscience.org/library/papers/31205469 | PubMed |
| 27724887 | Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. | BMC Cancer | 2016 | https://conductscience.org/library/papers/27724887 | PubMed |
| 26137913 | Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA. | Sci Rep | 2015 | https://conductscience.org/library/papers/26137913 | PubMed |
| 23761814 | High efficacy of combination chemotherapy with S-1 and low-dose docetaxel for the treatment of highly advanced gastric cancer with peritoneal dissemination: A case report. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23761814 | PubMed |
| 21283405 | Malignancy in the aged: two 'cures' of stomach cancer. | Can Fam Physician | 1983 | https://conductscience.org/library/papers/21283405 | PubMed |
| 20396554 | Randomized phase III trial of cisplatin, epirubicin, leucovorin, 5-fluorouracil (PELF) combination versus 5-fluorouracil alone as adjuvant chemotherapy in curative resected stage III gastric cancer. | Cancer Res Treat | 2004 | https://conductscience.org/library/papers/20396554 | PubMed |
| 19956484 | Chemotherapy for advanced gastric cancer: slow but further progress. | Cancer Res Treat | 2005 | https://conductscience.org/library/papers/19956484 | PubMed |
| 18756042 | Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. | J Korean Med Sci | 2008 | https://conductscience.org/library/papers/18756042 | PubMed |
| 17949350 | Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues. | Hum Cell | 2007 | https://conductscience.org/library/papers/17949350 | PubMed |
| 12966415 | Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12966415 | PubMed |
| 11291830 | A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies. | Invest New Drugs | 2001 | https://conductscience.org/library/papers/11291830 | PubMed |
| 9013471 | Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. | Med Oncol | 1996 | https://conductscience.org/library/papers/9013471 | PubMed |
| 6793759 | Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach. | Jpn J Surg | 1981 | https://conductscience.org/library/papers/6793759 | PubMed |
| 6668775 | Combination chemotherapy enhances survival of patients with unresectable gastric cancer. | Jpn J Surg | 1983 | https://conductscience.org/library/papers/6668775 | PubMed |
| 6406513 | Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6406513 | PubMed |
| 6349141 | An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. | World J Surg | 1983 | https://conductscience.org/library/papers/6349141 | PubMed |
| 6165425 | Chemotherapy following palliative resection of gastric cancer. | Br J Surg | 1981 | https://conductscience.org/library/papers/6165425 | PubMed |
| 3902267 | The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3902267 | PubMed |
| 1960901 | The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case. | Jpn J Surg | 1991 | https://conductscience.org/library/papers/1960901 | PubMed |
| 387542 | Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study. | Gut | 1979 | https://conductscience.org/library/papers/387542 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4279136
GET https://conductscience.org/api/papers/v1/4279136/cited_by?page=2